Lilly Immergluck to Antibodies, Neutralizing
This is a "connection" page, showing publications Lilly Immergluck has written about Antibodies, Neutralizing.
Connection Strength
0.507
-
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2025 Feb 05; 80(1):223-227.
Score: 0.228
-
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost. Nat Commun. 2025 Jan 17; 16(1):759.
Score: 0.227
-
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial. Clin Infect Dis. 2023 08 22; 77(4):560-564.
Score: 0.052